Wells Fargo & Company Rocket Pharmaceuticals, Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RCKT
# of Institutions
194Shares Held
92.3MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$298 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$154 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$104 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$97.7 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$72.8 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.27B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...